Myriad Genetics, Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-4
Book Value Per Share
$4
Free Cash Flow Per Share
$0
Cash Per Share
$2
Revenue Per Share
$9
OCF Per Share
$0
Return on Equity
-68.5%
Return on Assets
-42.2%
Return on Invested Capital
-49.8%
Debt to Equity
0.33
Current Ratio
2.49
Quick Ratio
2.26
Asset Turnover
0.95
Days Sales Outstanding
51.04
Days Payables Outstanding
44.17
Days Inventory On Hand
45.05
Cash Conversion Cycle
51.93
R&D / Revenue
13.0%
SBC / Revenue
4.3%
Capex / Revenue
—
Working Capital
$199M
Net Current Asset Value
$-6M
Invested Capital
$488M
OCF / Net Income
-0.00
FCF / Net Income
-0.00
Accruals Ratio (Sloan)
-52.0%
Net Debt
$-30M
Net Debt / EBITDA
0.09
Interest Coverage
-36.88
Cash Coverage
0.17
Capex Coverage
—
Tangible Common Equity
$163M
TCE / Total Assets
23.1%
Goodwill / Total Assets
7.3%
NOPAT
$-306M
Cash ROIC
0.3%
WC / Revenue
24.1%
Capex / D&A
—
Reinvestment Rate
13.9%
Total Payout Ratio
—
Asset Growth vs Revenue Growth
-29.7%
Revenue 5Y CAGR
8.2%
EPS 5Y CAGR
—
FCF 5Y CAGR
—
EBITDA 5Y CAGR
—
Book Value 5Y CAGR
-16.0%
Stock Price (FY-end)
$6
Market Cap
$569M
P/E Ratio
—
P/S Ratio
0.69
P/B Ratio
1.55
P/TB Ratio
3.49
P/OCF Ratio
316.38
P/FCF Ratio
316.38
Enterprise Value
$540M
EV / EBITDA
—
EV / Sales
0.65
EV / FCF
299.88
FCF Yield
0.3%
Shareholder Yield
-6.2%
Buyback Yield
—
R&D Yield
18.8%
Capex Yield
—
Operating Leverage
—
Graham Number
—
Shares Variation (YoY)
2.2%
Beta (5Y)
1.35
Cost of Equity
11.3%
Cost of Debt (after tax)
6.9%
WACC
10.5%
ROIC - WACC Spread
-60.3%
52W High
$15
52W Low
$4
Trailing Return 1Y
-54.2%
Trailing Return 5Y
-66.9%
F-Score (Piotroski)
5.00
Z-Score (Altman)
-1.52
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.